Interleukin-1 Receptor Antagonist Ameliorates Neonatal Lipopolysaccharide-Induced Long-Lasting Hyperalgesia in the Adult Rats

Toxicology - Ireland
doi 10.1016/j.tox.2010.10.002
Full Text
Abstract

Available in full text

Categories
Toxicology
Date
Authors
Publisher

Elsevier BV

Related search

Melatonin Ameliorates Brain Injury Induced by Systemic Lipopolysaccharide in Neonatal Rats

Neuroscience
Neuroscience
2014English

Neonatal Lipopolysaccharide Exposure Induces Long-Lasting Learning Impairment, Less Anxiety-Like Response and Hippocampal Injury in Adult Rats

Neuroscience
Neuroscience
2013English

Interleukin-1, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist

Proceedings of the Nutrition Society
MedicineNutritionDietetics
1994English

Ranitidine, a Histamine-2 Receptor Antagonist, Ameliorates Caerulein-Induced Pancreatitis in Rats

The Showa University Journal of Medical Sciences
2008English

TNF-α Antagonist Attenuates Systemic Lipopolysaccharide-Induced Brain White Matter Injury in Neonatal Rats

BMC Neuroscience
NeuroscienceCellularMolecular Neuroscience
2019English

Triptolide Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Rats

European Journal of Medical Research
Medicine
2013English

Retraction Note: Triptolide Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Rats

European Journal of Medical Research
Medicine
2015English

Arthritis Gene Therapy Using the Interleukin-1 Receptor Antagonist

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

A Bioartificial Liver Device Secreting Interleukin-1 Receptor Antagonist for the Treatment of Hepatic Failure in Rats

Journal of Surgical Research
Surgery
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy